Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke

In 1995, the NINDS (National Institute of Neurological Disorders and Stroke) tPA (tissue plasminogen activator) Stroke Study Group published the results of a large multicenter clinical trial demonstrating efficacy of intravenous tPA by revealing a 30% relative risk reduction (absolute risk reduction...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Chapman, Sherita N, Mehndiratta, Prachi, Johansen, Michelle C, McMurry, Timothy L, Johnston, Karen C, Southerland, Andrew M
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2014
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938499/
https://ncbi.nlm.nih.gov/pubmed/24591838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S39213
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki